Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heran Partners is a Belgian venture capital firm founded in 2020 that invests in early-stage MedTech and HealthTech startups across Europe. They focus on disruptive technologies at the intersection of life sciences and data—such as medical devices, AI-driven diagnostics/monitoring tools—and have supported notable ventures like Icometrix (AI for brain imaging) and Hypervision Surgical (surgical imaging/data analytics). The team provides both capital (€5M typical check size) and strategic guidance to portfolio companies. Successful exits include BlueBee and PharmaFluidics. The leadership team includes Annie Vereecken (Founding Partner), Katleen Vandersmissen (Managing Partner), Herman Verrelst (Founding Partner), and Joris Mortelmans (CFO)[1][2][3][5][6][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heran Partners.